Literature DB >> 20452076

The influence of pomegranate by-product and punicalagins on selected groups of human intestinal microbiota.

Dobroslawa Bialonska1, Priya Ramnani, Sashi G Kasimsetty, Kesava R Muntha, Glenn R Gibson, Daneel Ferreira.   

Abstract

We have examined the gut bacterial metabolism of pomegranate by-product (POMx) and major pomegranate polyphenols, punicalagins, using pH-controlled, stirred, batch culture fermentation systems reflective of the distal region of the human large intestine. Incubation of POMx or punicalagins with faecal bacteria resulted in formation of the dibenzopyranone-type urolithins. The time course profile confirmed the tetrahydroxylated urolithin D as the first product of microbial transformation, followed by compounds with decreasing number of phenolic hydroxy groups: the trihydroxy analogue urolithin C and dihydroxylated urolithin A. POMx exposure enhanced the growth of total bacteria, Bifidobacterium spp. and Lactobacillus spp., without influencing the Clostridium coccoides-Eubacterium rectale group and the C. histolyticum group. In addition, POMx increased concentrations of short chain fatty acids (SCFA) viz. acetate, propionate and butyrate in the fermentation medium. Punicalagins did not affect the growth of bacteria or production of SCFA. The results suggest that POMx oligomers, composed of gallic acid, ellagic acid and glucose units, may account for the enhanced growth of probiotic bacteria. Copyright 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20452076     DOI: 10.1016/j.ijfoodmicro.2010.03.038

Source DB:  PubMed          Journal:  Int J Food Microbiol        ISSN: 0168-1605            Impact factor:   5.277


  53 in total

1.  Urolithins impair cell proliferation, arrest the cell cycle and induce apoptosis in UMUC3 bladder cancer cells.

Authors:  Joana Liberal; Anália Carmo; Célia Gomes; Maria Teresa Cruz; Maria Teresa Batista
Journal:  Invest New Drugs       Date:  2017-06-20       Impact factor: 3.850

Review 2.  Diet, the gut microbiome, and epigenetics.

Authors:  Meredith A J Hullar; Benjamin C Fu
Journal:  Cancer J       Date:  2014 May-Jun       Impact factor: 3.360

Review 3.  Linking dietary patterns with gut microbial composition and function.

Authors:  Amy M Sheflin; Christopher L Melby; Franck Carbonero; Tiffany L Weir
Journal:  Gut Microbes       Date:  2016-12-14

Review 4.  Enteric microbiota leads to new therapeutic strategies for ulcerative colitis.

Authors:  Wei-Xu Chen; Li-Hua Ren; Rui-Hua Shi
Journal:  World J Gastroenterol       Date:  2014-11-14       Impact factor: 5.742

Review 5.  Microglia, Lifestyle Stress, and Neurodegeneration.

Authors:  Charlotte Madore; Zhuoran Yin; Jeffrey Leibowitz; Oleg Butovsky
Journal:  Immunity       Date:  2020-01-07       Impact factor: 31.745

6.  Enhanced activity of punicalagin delivered via polymeric implants against benzo[a]pyrene-induced DNA adducts.

Authors:  Farrukh Aqil; Manicka V Vadhanam; Ramesh C Gupta
Journal:  Mutat Res       Date:  2012-01-05       Impact factor: 2.433

7.  Gut microbiota, dietary phytochemicals and benefits to human health.

Authors:  Ran Yin; Hsiao-Chen Kuo; Rasika Hudlikar; Davit Sargsyan; Shanyi Li; Lujing Wang; Renyi Wu; Ah-Ng Kong
Journal:  Curr Pharmacol Rep       Date:  2019-08-19

8.  Pomegranate polyphenols and extract inhibit nuclear factor of activated T-cell activity and microglial activation in vitro and in a transgenic mouse model of Alzheimer disease.

Authors:  Lalida Rojanathammanee; Kendra L Puig; Colin K Combs
Journal:  J Nutr       Date:  2013-03-06       Impact factor: 4.798

9.  Behavioral effects of Citrus limon and Punica granatum combinations in rats.

Authors:  Azra Riaz; Rafeeq Alam Khan
Journal:  Metab Brain Dis       Date:  2016-08-11       Impact factor: 3.584

10.  Control of Virulent Listeria monocytogenes Originating from Dairy Products and Cattle Environment Using Marine Algal Extracts, Silver Nanoparticles Thereof, and Quaternary Disinfectants.

Authors:  Mona A El-Zamkan; Bassma A Hendy; Hassan Mahmoud Diab; Najat Marraiki; Gaber El-Saber Batiha; Hani Saber; Waleed Younis; Shankar Thangamani; Khalid J Alzahrani; Ahmed Shaban Ahmed
Journal:  Infect Drug Resist       Date:  2021-07-15       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.